213 related articles for article (PubMed ID: 16357139)
1. A putative role for psoriasin in breast tumor progression.
Krop I; März A; Carlsson H; Li X; Bloushtain-Qimron N; Hu M; Gelman R; Sabel MS; Schnitt S; Ramaswamy S; Kleer CG; Enerbäck C; Polyak K
Cancer Res; 2005 Dec; 65(24):11326-34. PubMed ID: 16357139
[TBL] [Abstract][Full Text] [Related]
2. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer.
Emberley ED; Niu Y; Njue C; Kliewer EV; Murphy LC; Watson PH
Clin Cancer Res; 2003 Jul; 9(7):2627-31. PubMed ID: 12855640
[TBL] [Abstract][Full Text] [Related]
3. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
4. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast.
Vogl G; Dietze O; Hauser-Kronberger C
Histopathology; 2005 Dec; 47(6):617-24. PubMed ID: 16324200
[TBL] [Abstract][Full Text] [Related]
6. Psoriasin interacts with Jab1 and influences breast cancer progression.
Emberley ED; Niu Y; Leygue E; Tomes L; Gietz RD; Murphy LC; Watson PH
Cancer Res; 2003 Apr; 63(8):1954-61. PubMed ID: 12702588
[TBL] [Abstract][Full Text] [Related]
7. Psoriasin expression in mammary epithelial cells in vitro and in vivo.
Enerbäck C; Porter DA; Seth P; Sgroi D; Gaudet J; Weremowicz S; Morton CC; Schnitt S; Pitts RL; Stampl J; Barnhart K; Polyak K
Cancer Res; 2002 Jan; 62(1):43-7. PubMed ID: 11782356
[TBL] [Abstract][Full Text] [Related]
8. Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development.
Carlsson H; Petersson S; Enerbäck C
Int J Oncol; 2005 Dec; 27(6):1473-81. PubMed ID: 16273201
[TBL] [Abstract][Full Text] [Related]
9. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
10. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer.
Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):467-74. PubMed ID: 17255267
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components.
Yamasaki T; Tsuda H; Imazeki N; Matsubara O
Pathol Int; 2005 May; 55(5):255-63. PubMed ID: 15871723
[TBL] [Abstract][Full Text] [Related]
13. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
14. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
15. Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival.
Campo L; Turley H; Han C; Pezzella F; Gatter KC; Harris AL; Fox SB
J Pathol; 2005 Apr; 205(5):585-91. PubMed ID: 15776477
[TBL] [Abstract][Full Text] [Related]
16. S100A7 (psoriasin) influences immune response genes in human breast cancer.
Mandal S; Curtis L; Pind M; Murphy LC; Watson PH
Exp Cell Res; 2007 Aug; 313(14):3016-25. PubMed ID: 17560571
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma.
Leygue E; Snell L; Hiller T; Dotzlaw H; Hole K; Murphy LC; Watson PH
Cancer Res; 1996 Oct; 56(20):4606-9. PubMed ID: 8840971
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.
Garvin S; Dabrosin C
Cancer Res; 2003 Dec; 63(24):8742-8. PubMed ID: 14695189
[TBL] [Abstract][Full Text] [Related]
19. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
